NEWS : Padmashree Dr. Ramakant Deshpande, Executive Chairman and Director of ACI, receiving an award for the Best Healthcare Entrepreneur at Global Awards for Excellence in Quality Management & Leadership * ACI DAYCARE-BORIVALI 4 Feb launching of centre by the hands of cabinet Minister Shree Vinod Tawde & sitting MP Shree Gopal Shetty * Click Here To Take Appointment!!! * We have Sucessfully performed 250 Robotic Surgery till date *
BLOG : Afatinib Superior to Erlotinin Liquid Biopsy gives 100% accuracy Head and Neck New Urinary Molecular Test

About Ajinkya Vichare

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
web-banner

World Health Organization (WHO) marks the theme of 31 May of the World No Tobacco Day in 2016 as “Get ready for plain packaging “. Plain packaging is a measure that restrict or prohibit the use of logos, colors, brand images or promotional information on tobacco packaging other than brand names and product names displayed…

A non invasive urine exosome gene expression assay is good news for Prostate screening. A urinary 3-gene expression assay discriminates high-grade (??GS7) versus low-grade (GS6) prostate cancer and benign disease. ?This will prevent overdiagnosis and help better management of individual patients.

Patients with Chronic Myeloid Leukemia (CML) typically a translocation between chromosome 9 and 22 – resulting in what is called the philadelphia chromosome. At Asian Cancer Institute, we know that this is not enough information to treat patients correctly. As the time passes, addtional chromosomal abnormalities (ACA) can emergence and need to be monitored. Based…

Gastrointestinal stromal tumors (GISTs), which lack KIT and PDGFRA gene mutations (wild type), are seen mainly in children and respond poorly to standard targeted therapy. At Asian Cancer Institute, we know how to focus on a personalized approach for such patients to improve outcome. ?How do we do this? We are up to date and…

This month Xalkori (crizotinib) was approved by the U.S. Food and Drug Administration to treat advanced non-small-cell lung cancer (NSCLC) with tumors that have a rareROS1 gene mutation. This is in addition to the drug’s approval (in 2011) for ALK positive advanced NSCLC. At Asian Cancer Institute, we have ?renown international experts who have contributed…

Patients with chronic myeloid leukemia (CML) are always worried when their WBC Count increases. At Asian Cancer Institute our expert Medical Oncologists and Hematologist understand very well which of such patients have a problem and which don’t. We know that significant number of patients treated with the tyrosine kinase inhibitor (TKI) dasatinib experience increase in…

?Recently the Journal of Clinical Oncology, published finding that persons heterozygous for the CHEK2*1100delC germline mutation not only have a higher risk of breast cancer, but also a much higher risk for other cancers as well. CHEK2 is a cell-cycle checkpoint regulator. The study involved data from 86,975 individuals between 2003 and 2010. Among these,…

Meta-analysis of 15 studies showed that Prophylactic bilateral salpingo-oophorectomy (PBSO) and bilateral prophylactic mastectomy (BPM) were both associated with a decreased Breast Cancer risk in BRCA1/2 mutation carriers. Similar findings were observed in BRCA1 and BRCA2 mutation carriers separately. Moreover, contralateral prophylactic mastectomy (CPM) significantly decreased contralateral BC incidence in BRCA1/2 mutation carriers. In addition,…

ASCO Names Clifford Hudis As CEO. The Cancer Letter (3/27) reports in continuing coverage that the American Society of Clinical Oncology has elected Clifford Hudis as CEO. Hudis, who had previously served as ASCO president in 2013 and 2014, is “chief of Breast Medicine Service as well as vice president for government relations and chief…

Research Reveals Cancer Patients Who Choose To Die At Home May Live Longer. N?ew research from Japan revealed that cancer patients who choose to die at home may live longer than those who remain in the hospital. Data from nearly 1,600 patients who died in hospital and 500 who died at home shows this. The…

Left Menu Icon